Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/26/2026

CT Angiography for Pulmonary Embolism: Implications for Coronary Artery Disease Assessment

Limitations of Standard CTPA for CAD

  • A standard CT pulmonary angiogram (CTPA) performed with a PE protocol is not optimized for coronary artery disease (CAD) assessment and should not be used as a primary method for CAD evaluation; it may only incidentally reveal significant coronary calcifications or gross coronary abnormalities. – American College of Radiology 1

  • Standard CTPA is non‑ECG‑gated, resulting in cardiac motion artifacts that markedly degrade visualization of the coronary arteries. – American College of Radiology 1

  • The contrast injection timing in a routine PE protocol is tuned for pulmonary arterial enhancement, not for coronary arterial enhancement, making detailed coronary assessment unreliable. – American College of Radiology 1

  • Routine PE acquisition lacks the thin‑section reconstructions and three‑dimensional rendering required for dedicated coronary evaluation. – American College of Radiology 3

Triple Rule‑Out (TRO) Protocol

  • A specialized “triple rule‑out” CT protocol exists that can simultaneously evaluate for pulmonary embolism, acute aortic syndrome, and acute coronary syndrome in a single study. – American College of Radiology [1][2]4

  • The TRO protocol employs ECG‑gating and optimized contrast timing to provide high‑quality imaging of the pulmonary vasculature, thoracic aorta, and coronary arteries. – American College of Radiology [1][2]

  • Although technically feasible with excellent diagnostic performance reported (≈100 % sensitivity and 98 % specificity for cardiovascular disease), the TRO approach has not been validated in large‑scale clinical trials and is therefore not routinely recommended. – American College of Radiology [1][2]4

  • Recent evidence shows that among patients clinically suspected of PE, the prevalence of acute coronary syndrome is only ≈0.5 %, supporting the use of dedicated CTPA (rather than TRO) for routine PE evaluation. – American College of Radiology [1][2]

Clinical Recommendations

  • When ordering imaging for suspected PE in patients with known or suspected CAD, clinicians should recognize that a standard CTPA will not adequately assess coronary arteries; any visible coronary calcifications are incidental and provide only limited prognostic information. – American College of Radiology 1

  • Definitive functional assessment of CAD requires a dedicated coronary CTA with ECG‑gating or alternative cardiac testing modalities. – American College of Radiology 1